van der Schaft DW - Search Results

1

Effect of culture conditions on endothelial cell growth and responsiveness.

Relou IA, Damen CA, van der Schaft DW, Groenewegen G, Griffioen AW. Relou IA, et al. Among authors: van der schaft dw. Tissue Cell. 1998 Oct;30(5):525-30. doi: 10.1016/s0040-8166(98)80032-3. Tissue Cell. 1998. PMID: 9839475

2

The antiangiogenic properties of bactericidal/permeability-increasing protein (BPI).

van der Schaft DW, Wagstaff J, Mayo KH, Griffioen AW. van der Schaft DW, et al. Ann Med. 2002;34(1):19-27. doi: 10.1080/078538902317338607. Ann Med. 2002. PMID: 12014429 Review.

3

Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activity.

Ahmed B, Van Eijk LI, Bouma-Ter Steege JC, Van Der Schaft DW, Van Esch AM, Joosten-Achjanie SR, Lambin P, Landuyt W, Griffioen AW. Ahmed B, et al. Among authors: van esch am, van eijk li, van der schaft dw. Int J Cancer. 2003 May 20;105(1):20-5. doi: 10.1002/ijc.11010. Int J Cancer. 2003. PMID: 12672025 Free article.

4

Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells.

van der Schaft DW, Toebes EA, Haseman JR, Mayo KH, Griffioen AW. van der Schaft DW, et al. Blood. 2000 Jul 1;96(1):176-81. Blood. 2000. PMID: 10891448 Free article.

5

Anginex, a designed peptide that inhibits angiogenesis.

Griffioen AW, van der Schaft DW, Barendsz-Janson AF, Cox A, Struijker Boudier HA, Hillen HF, Mayo KH. Griffioen AW, et al. Among authors: van der schaft dw. Biochem J. 2001 Mar 1;354(Pt 2):233-42. doi: 10.1042/0264-6021:3540233. Biochem J. 2001. PMID: 11171099 Free PMC article.

6

The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.

van der Schaft DW, Dings RP, de Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, Bouma-Ter Steege JC, Wagstaff J, Mayo KH, Griffioen AW. van der Schaft DW, et al. Among authors: van eijk li. FASEB J. 2002 Dec;16(14):1991-3. doi: 10.1096/fj.02-0509fje. Epub 2002 Oct 18. FASEB J. 2002. PMID: 12397082

7

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

Dirkx AE, oude Egbrink MG, Castermans K, van der Schaft DW, Thijssen VL, Dings RP, Kwee L, Mayo KH, Wagstaff J, Bouma-ter Steege JC, Griffioen AW. Dirkx AE, et al. Among authors: van der schaft dw. FASEB J. 2006 Apr;20(6):621-30. doi: 10.1096/fj.05-4493com. FASEB J. 2006. PMID: 16581970

8

Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells.

Mayo KH, van der Schaft DW, Griffioen AW. Mayo KH, et al. Among authors: van der schaft dw. Angiogenesis. 2001;4(1):45-51. doi: 10.1023/a:1016672117477. Angiogenesis. 2001. PMID: 11824378

9

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.

Paulis YW, Huijbers EJ, van der Schaft DW, Soetekouw PM, Pauwels P, Tjan-Heijnen VC, Griffioen AW. Paulis YW, et al. Among authors: van der schaft dw. Oncotarget. 2015 Aug 14;6(23):19634-46. doi: 10.18632/oncotarget.3839. Oncotarget. 2015. PMID: 26189059 Free PMC article.

10

Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma.

Pardali E, van der Schaft DW, Wiercinska E, Gorter A, Hogendoorn PC, Griffioen AW, ten Dijke P. Pardali E, et al. Among authors: van der schaft dw. Oncogene. 2011 Jan 20;30(3):334-45. doi: 10.1038/onc.2010.418. Epub 2010 Sep 20. Oncogene. 2011. PMID: 20856203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page